GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,882,000 | -0.1% | 66,200 | 0.0% | 1.44% | +8.7% |
| Q1 2022 | $2,884,000 | -1.2% | 66,200 | 0.0% | 1.33% | -1.6% |
| Q4 2021 | $2,919,000 | +19.0% | 66,200 | +3.1% | 1.35% | +7.8% |
| Q3 2021 | $2,453,000 | -4.0% | 64,200 | 0.0% | 1.25% | -2.9% |
| Q2 2021 | $2,556,000 | +118.3% | 64,200 | +95.7% | 1.29% | +105.6% |
| Q1 2021 | $1,171,000 | -1.2% | 32,800 | +1.9% | 0.63% | -5.6% |
| Q4 2020 | $1,185,000 | +5.3% | 32,200 | +7.7% | 0.66% | +0.3% |
| Q3 2020 | $1,125,000 | -7.8% | 29,900 | 0.0% | 0.66% | -15.5% |
| Q2 2020 | $1,220,000 | +7.7% | 29,900 | 0.0% | 0.78% | -4.5% |
| Q1 2020 | $1,133,000 | -19.4% | 29,900 | 0.0% | 0.82% | -7.4% |
| Q4 2019 | $1,405,000 | +10.1% | 29,900 | 0.0% | 0.88% | +7.8% |
| Q3 2019 | $1,276,000 | +6.6% | 29,900 | 0.0% | 0.82% | +9.8% |
| Q2 2019 | $1,197,000 | -4.2% | 29,900 | 0.0% | 0.75% | -8.0% |
| Q1 2019 | $1,250,000 | +10.1% | 29,900 | +0.7% | 0.81% | -4.8% |
| Q4 2018 | $1,135,000 | -4.9% | 29,700 | 0.0% | 0.85% | +9.4% |
| Q3 2018 | $1,193,000 | -0.3% | 29,700 | 0.0% | 0.78% | -7.8% |
| Q2 2018 | $1,197,000 | +3.2% | 29,700 | 0.0% | 0.85% | +4.7% |
| Q1 2018 | $1,160,000 | +10.2% | 29,700 | 0.0% | 0.81% | +13.0% |
| Q4 2017 | $1,053,000 | -37.8% | 29,700 | -28.8% | 0.72% | -41.0% |
| Q3 2017 | $1,693,000 | +65.0% | 41,700 | +75.2% | 1.21% | +54.3% |
| Q2 2017 | $1,026,000 | +2.3% | 23,800 | 0.0% | 0.78% | -2.0% |
| Q1 2017 | $1,003,000 | +9.4% | 23,800 | 0.0% | 0.80% | -2.8% |
| Q4 2016 | $917,000 | -20.4% | 23,800 | -10.9% | 0.82% | -13.8% |
| Q3 2016 | $1,152,000 | +0.3% | 26,700 | +0.8% | 0.96% | -0.9% |
| Q2 2016 | $1,149,000 | +6.9% | 26,500 | 0.0% | 0.96% | +4.3% |
| Q1 2016 | $1,075,000 | +0.6% | 26,500 | 0.0% | 0.92% | -3.8% |
| Q4 2015 | $1,069,000 | +9.1% | 26,500 | +3.9% | 0.96% | +2.9% |
| Q3 2015 | $980,000 | +4.6% | 25,500 | +13.3% | 0.94% | +10.8% |
| Q2 2015 | $937,000 | -6.4% | 22,500 | +3.7% | 0.84% | -5.1% |
| Q1 2015 | $1,001,000 | +8.0% | 21,700 | 0.0% | 0.89% | +10.8% |
| Q4 2014 | $927,000 | -7.1% | 21,700 | 0.0% | 0.80% | -10.6% |
| Q3 2014 | $998,000 | -14.0% | 21,700 | 0.0% | 0.90% | -14.7% |
| Q2 2014 | $1,161,000 | -8.3% | 21,700 | -8.4% | 1.05% | -5.5% |
| Q1 2014 | $1,266,000 | +0.1% | 23,700 | 0.0% | 1.11% | -0.4% |
| Q4 2013 | $1,265,000 | +6.4% | 23,700 | 0.0% | 1.12% | -2.1% |
| Q3 2013 | $1,189,000 | +0.4% | 23,700 | 0.0% | 1.14% | -2.7% |
| Q2 2013 | $1,184,000 | – | 23,700 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |